Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2014 2
2015 1
2018 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome"
Page 1
Testosterone treatment longer than 1 year shows more effects on functional hypogonadism and related metabolic, vascular, diabetic and obesity parameters (results of the 2-year clinical trial).
Groti Antonič K, Antonič B, Žuran I, Pfeifer M. Groti Antonič K, et al. Aging Male. 2020 Dec;23(5):1442-1454. doi: 10.1080/13685538.2020.1793132. Epub 2020 Aug 26. Aging Male. 2020. PMID: 32844712 Clinical Trial.
OBJECTIVE: We evaluated long-term effects of testosterone undecanoate on glycemic control, metabolic syndrome, vascular function and morphology in obese men with functional hypogonadism (FH) and type 2 diabetes (T2D) in a 2-year prospective clinical trial …
OBJECTIVE: We evaluated long-term effects of testosterone undecanoate on glycemic control, metabolic syndrome, vascular function and …
Multiple phenotypes in phosphoglucomutase 1 deficiency.
Tegtmeyer LC, Rust S, van Scherpenzeel M, Ng BG, Losfeld ME, Timal S, Raymond K, He P, Ichikawa M, Veltman J, Huijben K, Shin YS, Sharma V, Adamowicz M, Lammens M, Reunert J, Witten A, Schrapers E, Matthijs G, Jaeken J, Rymen D, Stojkovic T, Laforêt P, Petit F, Aumaître O, Czarnowska E, Piraud M, Podskarbi T, Stanley CA, Matalon R, Burda P, Seyyedi S, Debus V, Socha P, Sykut-Cegielska J, van Spronsen F, de Meirleir L, Vajro P, DeClue T, Ficicioglu C, Wada Y, Wevers RA, Vanderschaeghe D, Callewaert N, Fingerhut R, van Schaftingen E, Freeze HH, Morava E, Lefeber DJ, Marquardt T. Tegtmeyer LC, et al. N Engl J Med. 2014 Feb 6;370(6):533-42. doi: 10.1056/NEJMoa1206605. N Engl J Med. 2014. PMID: 24499211 Free PMC article.
BACKGROUND: Congenital disorders of glycosylation are genetic syndromes that result in impaired glycoprotein production. We evaluated patients who had a novel recessive disorder of glycosylation, with a range of clinical manifestations that included hepatopathy, bif …
BACKGROUND: Congenital disorders of glycosylation are genetic syndromes that result in impaired glycoprotein production. We evaluated …
The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
Groti K, Žuran I, Antonič B, Foršnarič L, Pfeifer M. Groti K, et al. Aging Male. 2018 Sep;21(3):158-169. doi: 10.1080/13685538.2018.1468429. Epub 2018 Apr 30. Aging Male. 2018. PMID: 29708829 Clinical Trial.
OBJECTIVE: This study set out to assess effects of testosterone replacement therapy (TRT) on parameters of metabolic syndrome and vascular function in obese hypogonadal males with type 2 diabetes mellitus (DM2). STUDY DESIGN: Fifty-five obese hypogonadal diab …
OBJECTIVE: This study set out to assess effects of testosterone replacement therapy (TRT) on parameters of metabolic syndrome and vas …
Effect of androgen replacement therapy on atherosclerotic risk markers in young-to-middle-aged men with idiopathic hypogonadotropic hypogonadism.
Doğan BA, Karakılıç E, Tuna MM, Arduç A, Berker D, Güler S. Doğan BA, et al. Clin Endocrinol (Oxf). 2015 Mar;82(3):422-8. doi: 10.1111/cen.12617. Epub 2014 Nov 5. Clin Endocrinol (Oxf). 2015. PMID: 25280063
Androgen replacement therapy was given according to the Algorithm of Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes (2010; Journal of Clinical Endocrinology and Metabolism, 95, 2536). ...Endothelial function was assessed with brachial flow-medi …
Androgen replacement therapy was given according to the Algorithm of Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes …
Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome.
Dokras A, Jagasia DH, Maifeld M, Sinkey CA, VanVoorhis BJ, Haynes WG. Dokras A, et al. Fertil Steril. 2006 Dec;86(6):1702-9. doi: 10.1016/j.fertnstert.2006.05.038. Epub 2006 Oct 24. Fertil Steril. 2006. PMID: 17067587 Free article. Clinical Trial.
OBJECTIVE: Polycystic ovary syndrome (PCOS) is associated with biochemical evidence of early atherosclerosis; however, data regarding vascular function are controversial. ...INTERVENTION(S): Vascular function was assessed by measuring forearm vasodilatation in response to …
OBJECTIVE: Polycystic ovary syndrome (PCOS) is associated with biochemical evidence of early atherosclerosis; however, data regarding …
A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism.
Ostberg JE, Storry C, Donald AE, Attar MJ, Halcox JP, Conway GS. Ostberg JE, et al. Clin Endocrinol (Oxf). 2007 Apr;66(4):557-64. doi: 10.1111/j.1365-2265.2007.02772.x. Clin Endocrinol (Oxf). 2007. PMID: 17371475 Clinical Trial.
OBJECTIVE: Young hypogonadal women appear to have an increased risk of cardiovascular disease. ...DESIGN: Nine-month sequential dose-ranging study. PATIENTS: A total of 25 young hypogonadal women (Turner Syndrome, n = 14; 46,XX gonadal dysgenesis, n = 9), hyp …
OBJECTIVE: Young hypogonadal women appear to have an increased risk of cardiovascular disease. ...DESIGN: Nine-month sequential dose- …